Country (region) | Units | Whenever possible for pre-eclampsia | Women with severe pre-eclampsia | Women receiving MgSO4 | Whenever possible or sometimes for neuroprotection | Women without pre-eclampsia, HELLP or eclampsia | Women receiving MgSO4 |
---|---|---|---|---|---|---|---|
n | Percentage of units | n | Per cent | Percentage of units | n | Per cent | |
Belgium (Flanders) | 9 | 33.3 | 70 | 67.1 | 11.1 | 367 | 2.7 |
Estonia (whole country) | 3 | 33.3 | 19 | 21.1 | 0.0 | 93 | 3.2 |
France (Northern region, Burgundy, Ile-de-France) | 21 | 0.0 | 155 | 18.1 | 23.8 | 550 | 2.0 |
Germany (Hesse, Saarland) | 13 | 53.9 | 45 | 40.0 | 30.8 | 228 | 6.6 |
Italy (Lazio, Emilia-Romania, Marche) | 20 | 50.0 | 107 | 15.9 | 25.0 | 620 | 1.1 |
Netherlands (East-Central) | 2 | 50.0 | 45 | 91.1 | 50.0 | 206 | 0.5 |
Poland (Wielkopolska) | 2 | 100.0 | 5 | 60.0 | 100.0 | 114 | 12.3 |
Portugal (Northern and Lisbon) | 13 | 76.9 | 88 | 9.1 | 38.5 | 399 | 5.5 |
Sweden (Stockholm) | 4 | 0.0 | 40 | 40.0 | 0.0 | 147 | 0.0 |
UK (Northern, East Midlands, Yorkshire & Humber) | 32 | 46.9 | 146 | 50.0 | 15.6 | 934 | 1.3 |
Women with a non-anomalous live birth who received prenatal corticosteroids and delivered in a maternity unit with more than 20 very preterm deliveries annually (see online supplementary table S1 for exclusions by country).
MgSO4, magnesium sulfate.